Statement of Cash Flows (Tables)

9 Months Ended

Sep. 30, 2020

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheet to the total of the same such amounts shown in the Condensed Consolidated Statement of Cash Flows:

	September 30,		September 30,
	2020		2019
Cash and cash equivalents	$	1,573.0	$	1,384.8
Restricted cash included in Other noncurrent assets	13.6		12.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statement of Cash Flows	$	1,586.6	$	1,397.3

Restrictions on Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheet to the total of the same such amounts shown in the Condensed Consolidated Statement of Cash Flows:

	September 30,		September 30,
	2020		2019
Cash and cash equivalents	$	1,573.0	$	1,384.8
Restricted cash included in Other noncurrent assets	13.6		12.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statement of Cash Flows	$	1,586.6	$	1,397.3

Summary of Non-Cash Investing and Financing Activities

The following amounts were included in accounts payable, accrued expenses, and other liabilities:

	September 30,		December 31,		September 30,		December 31,
	2020		2019		2019		2018
Accrued capital expenditures	$	100.4	$	133.7	$	100.5	$	54.5